Study identifies a genetic driver of deadly prostate cancer
by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera
Updated on: March 12,2024
19
Study identifies a genetic driver of deadly prostate cancer
by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera
Updated on:March 12,2024
19